Archive \ Volume.17 2026 Issue 3

Who Governs the Digital Pharmacy Algorithm? An Integrative Review of Accountability, Regulation, and Professional Practice

, , ,
  1. Department of Digital Pharmacy Governance and Accountability, Faculty of Pharmacy, Novosibirsk State University, Novosibirsk, Russia.
  2. Department of AI Regulation and Professional Practice, Faculty of Pharmacy, Ural Federal University, Yekaterinburg, Russia.
  3. Department of Algorithm Governance in Pharmacy, Faculty of Pharmacy, Kazan Federal University, Kazan, Russia.

Abstract

Digital pharmacy algorithms are governed through legal, regulatory, organizational, commercial, professional, and patient-facing arrangements. These arrangements distribute authority unevenly and often separate formal accountability from practical control. To integrate evidence on who governs medication-related algorithms, where responsibilities arise across the lifecycle, and how monitoring, challenge, correction, and redress are allocated. An integrative review combined health, pharmacy, informatics, policy, ethical, and legal scholarship published from 2017 through 2026. Searches covered MEDLINE, Scopus, Web of Science Core Collection, International Pharmaceutical Abstracts, HeinOnline, and citation searching. Eligible peer-reviewed reports had to identify a governance actor, authority, responsibility, mechanism, or lifecycle stage relevant to digital pharmacy or medication-related algorithms. Records were deduplicated, screened, retrieved, appraised by source type, extracted into a structured governance framework, and synthesized through comparative thematic analysis. The search identified 556 records; 214 duplicates were removed, 342 records were screened, 68 reports were sought, 3 were not retrieved, and 65 full texts were assessed. Thirty reports representing 30 studies or scholarly analyses were included. Governance was distributed across regulators, healthcare organizations, vendors, developers, pharmacists, and patients, but the allocation of monitoring, incident investigation, correction, and redress was inconsistent. Formal regulatory authority did not reliably correspond to operational control. Pharmacists retained professional duties, while vendors and organizations controlled many technical and workflow conditions. Patient participation and contestability remained underdeveloped. Digital pharmacy algorithm governance is multilevel, fragmented, and lifecycle-dependent. Clearer allocation of authority, documentation, surveillance, escalation, and redress is needed before governance arrangements can be considered dependable.


Downloads: 20
Views: 96

How to cite:
Vancouver
Fedorova E, Volkov A, Morozova I, Kuznetsov D. Who Governs the Digital Pharmacy Algorithm? An Integrative Review of Accountability, Regulation, and Professional Practice. Arch Pharm Pract. 2026;17(3):19-27. https://doi.org/10.51847/RjpzvOQ1Ql
APA
Fedorova, E., Volkov, A., Morozova, I., & Kuznetsov, D. (2026). Who Governs the Digital Pharmacy Algorithm? An Integrative Review of Accountability, Regulation, and Professional Practice. Archives of Pharmacy Practice, 17(3), 19-27. https://doi.org/10.51847/RjpzvOQ1Ql

Download Citation
References
  1. Reddy S, Allan S, Coghlan S, Cooper P. A governance model for the application of AI in health care. J Am Med Inform Assoc. 2020;27(3):491-7. doi:10.1093/jamia/ocz192
  2. Vayena E, Blasimme A, Cohen IG. Machine learning in medicine: Addressing ethical challenges. PLoS Med. 2018;15(11). doi:10.1371/journal.pmed.1002689
  3. Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: A roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337-40. doi:10.1038/s41591-019-0548-6
  4. Habli I, Lawton T, Porter Z. Artificial intelligence in health care: Accountability and safety. Bull World Health Organ. 2020;98(4):251-6. doi:10.2471/BLT.19.237487
  5. Snyder H. Literature review as a research methodology: An overview and guidelines. J Bus Res. 2019;104:333-9. doi:10.1016/j.jbusres.2019.07.039
  6. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372. doi:10.1136/bmj.n71
  7. Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, et al. PRISMA-S: An extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10(1):39. doi:10.1186/s13643-020-01542-z
  8. Morley J, Machado CCV, Burr C, Cowls J, Joshi I, Taddeo M, et al. The ethics of AI in health care: A mapping review. Soc Sci Med. 2020;260:113172. doi:10.1016/j.socscimed.2020.113172
  9. Grote T, Berens P. On the ethics of algorithmic decision-making in healthcare. J Med Ethics. 2020;46(3):205-11. doi:10.1136/medethics-2019-105586
  10. Cutillo CM, Sharma KR, Foschini L, Kundu S, Mackintosh M, Mandl KD, et al. Machine intelligence in healthcare—perspectives on trustworthiness, explainability, usability, and transparency. NPJ Digit Med. 2020;3:47. doi:10.1038/s41746-020-0254-2
  11. Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, et al. Improving the content validity of the mixed methods appraisal tool: A modified e-Delphi study. J Clin Epidemiol. 2019;111:49-59.e1. doi:10.1016/j.jclinepi.2019.03.008
  12. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK, Chan AW, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nat Med. 2020;26(9):1364-74. doi:10.1038/s41591-020-1034-x
  13. Cruz Rivera S, Liu X, Chan AW, Denniston AK, Calvert MJ, Ashrafian H, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI extension. Nat Med. 2020;26(9):1351-63. doi:10.1038/s41591-020-1037-7
  14. Hatzimanolis J, Riley B, El-Den S, Aslani P, Zhou J, Chaar B. Applications of artificial intelligence in current pharmacy practice: A scoping review. Res Social Adm Pharm. 2025;21(3):134-41. doi:10.1016/j.sapharm.2024.12.007
  15. Benjamens S, Dhunnoo P, Meskó B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: An online database. NPJ Digit Med. 2020;3:118. doi:10.1038/s41746-020-00324-0
  16. Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): A comparative analysis. Lancet Digit Health. 2021;3(3). doi:10.1016/S2589-7500(20)30292-2
  17. Corny J, Rajkumar A, Martin O, Dode X, Lajonchère JP, Billuart O, et al. A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc. 2020;27(11):1688-94. doi:10.1093/jamia/ocaa154
  18. Day S, Shah V, Kaganoff S, Powelson S, Mathews SC. Assessing the clinical robustness of digital health startups: Cross-sectional observational analysis. J Med Internet Res. 2022;24(6). doi:10.2196/37677
  19. Blease C, Kaptchuk TJ, Bernstein MH, Mandl KD, Halamka JD, DesRoches CM. Artificial intelligence and the future of primary care: Exploratory qualitative study of UK general practitioners’ views. J Med Internet Res. 2019;21(3). doi:10.2196/12802
  20. Gustafson KA, Rowe C, Gavaza P, Bernknopf A, Nogid A, Hoffman A, et al. Pharmacists’ perceptions of artificial intelligence: A national survey. J Am Pharm Assoc (2003). 2025;65(1):102306. doi:10.1016/j.japh.2024.102306
  21. Hasan HE, Jaber D, Khabour OF, Alzoubi KH. Ethical considerations and concerns in the implementation of AI in pharmacy practice: A cross-sectional study. BMC Med Ethics. 2024;25(1):55. doi:10.1186/s12910-024-01062-8
  22. Graafsma J, Murphy RM, van de Garde EMW, Karapinar-Çarkit F, Derijks HJ, Hoge RHL, et al. The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: A scoping review. J Am Med Inform Assoc. 2024;31(6):1411-22. doi:10.1093/jamia/ocae076
  23. Wong A, Otles E, Donnelly JP, Krumm A, McCullough J, DeTroyer-Cooley O, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065-70. doi:10.1001/jamainternmed.2021.2626
  24. Embi PJ. Algorithmovigilance—advancing methods to analyze and monitor artificial intelligence-driven health care for effectiveness and equity. JAMA Netw Open. 2021;4(4). doi:10.1001/jamanetworkopen.2021.4622
  25. Duffourc M, Gerke S. Generative AI in health care and liability risks for physicians and safety concerns for patients. JAMA. 2023;330(4):313-4. doi:10.1001/jama.2023.9630
  26. Price WN 2nd, Gerke S, Cohen IG. Potential liability for physicians using artificial intelligence. JAMA. 2019;322(18):1765-6. doi:10.1001/jama.2019.15064
  27. McDougall RJ. Computer knows best? The need for value-flexibility in medical AI. J Med Ethics. 2019;45(3):156-60. doi:10.1136/medethics-2018-105118
  28. Char DS, Shah NH, Magnus D. Implementing machine learning in health care—addressing ethical challenges. N Engl J Med. 2018;378(11):981-3. doi:10.1056/NEJMp1714229
  29. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-53. doi:10.1126/science.aax2342
  30. Rajkomar A, Hardt M, Howell MD, Corrado G, Chin MH. Ensuring fairness in machine learning to advance health equity. Ann Intern Med. 2018;169(12):866-72. doi:10.7326/M18-1990
  31. McCradden MD, Joshi S, Mazwi M, Anderson JA. Ethical limitations of algorithmic fairness solutions in health care machine learning. Lancet Digit Health. 2020;2(5). doi:10.1016/S2589-7500(20)30065-0
  32. Amann J, Blasimme A, Vayena E, Frey D, Madai VI; Precise4Q Consortium. Explainability for artificial intelligence in healthcare: A multidisciplinary perspective. BMC Med Inform Decis Mak. 2020;20(1):310. doi:10.1186/s12911-020-01332-6
  33. Ghassemi M, Oakden-Rayner L, Beam AL. The false hope of current approaches to explainable artificial intelligence in health care. Lancet Digit Health. 2021;3(11). doi:10.1016/S2589-7500(21)00208-9
  34. Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med. 2022;28(5):924-33. doi:10.1038/s41591-022-01772-9

 

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.